US Satellite Award Winner
Meet our first ever 42PLUS1 winner!
Once again, we would like to thank all applicants, finalists, jury members and supporters for contributing to this great new competition 42PLUS1.
Alertgy, Inc.
Alertgy has developed a 100% non-invasive, real-time, real blood glucometer that lasts a long time.
CEO, Marc Rippen
Get ready for take-off - our 42PLUS1 Finalists at the DxPx US on 27th of July
From the many great applications we’ve received our jury chose 8 finalists to join the DxPx Galaxy and present their pitch at DxPx US on July 27th. We’re over the moon to announce our first ever 42PLUS1 finalists:
Andrej Babic, CEO
Adiposs Ltd
ImageBAT is a first-in-class medical imaging product for brown fat.
Baptiste Billoir, CFO
AgenT
The first blood test to diagnose Alzheimer’s from the asymptomatic stage.
Marc Rippen, CEO
Alertgy, Inc.
Alertgy has developed a 100% non-invasive, real-time, real blood glucometer that lasts a long time.
Felix Neumann, CEO
Countagen AB
A ready-to-use kit for the precise quantification and identification of gene editing events.
Joseph Skraba, CEO
Entvantage Diagnostics, Inc
ENTvantage Dx provides rapid diagnostic results to help providers improve antibiotic stewardship.
Caroline Hoedemaker, CEO
Neoneur LLC
Neoneur is a simple handheld telehealth device to track newborn develop using brain driven
patterns
Hiep-Hoa Nguyen, CEO
Pace Diagnostics
Delivering tuberculosis laboratory test results but without the lab for a fraction of cost, time, and the hassle
David Herbada, CEO
Sonosine Limited
The Pulsar 1 is a medical imaging diagnostic device that uses patented EMA imaging technology.
The Magnitude of the DxPx Galaxy
Our first application round is offically closed! Thank you to everyone who submitted their business plan – we’ve received A BIG NUMBER of innovative ideas and visions from many different countries. Check out which countries are already part of our Galaxy!
Travel to the DxPx Galaxy and end up where you need to be.
The startup universe is big.Really big.
This is why we focus on the DxPx Galaxy made of four planets: Diagnostics, Precision Medicine, Digital Health and Life Science Tools. The competition in this Galaxy is tough and each planet poses huge challenges for the inhabitants. If you want to make it in the world of Diagnostics, Precision Medicine, Digital Health and Life Science Tools, 42PLUS1 can help. This is why we take your startup on a journey through the DxPx Galaxy and provide the one answer to the challenges of today‘s founders.
Visibility on & off the stage.
Each application is reviewed by at least a dozen VCs and industry executives. We even share their feedback. If you make it on stage, we dedicate a 13 minute live pitch to your vision. We can guarantee that a huge crowd of renowned decision makers with genuine interest will attend your pitch!
Win over $ 1,500,000.
You’re not dreaming. 8 selected startups will compete at our DxPx Flagship Conference for at least $ 1,500,000. The funding will be granted to the three winners as convertible loan to build further value for the next financing round. Don’t miss the opportunity to give your startup a decisive boost!
Become one of our stars.
Each applicant is offered the opportunity to be featured in our network. Our stage divers will be actively promoted and get a dedicated spot in our DxPx Conference Brochure, made available to several thousands of investors, who frequently visit our Galaxy.
What's in it for you?Other than winningover $ 1,500,000?
Supporting startups and growth companies is what drives us at DxPx – we want you to make a real difference and accelerate your business! This is why we offer you the stage and attention from industry partners and investors that your ideas deserve. Save yourself a lot of time and pitch in front of renowned investors and decision makers, who deeply care about our DxPx Galaxy. There’s not only magic happening, but also money to win, prestige to conquer and awareness to build!
Don't panic – attend the 42plus1 pitch award
our jurors -
They know the DxPx Galaxy like the back of their hand
Proud to announce our
42PLUS1 US Satellite Award Jury
more to come...
Reetika Bhardwaj
Associate, ARCH Venture Partners
Rainer Christine
Partner, Earlybird Venture Capital
Matthias Essenpreis
Chief Technology Officer, Roche Diagnostics
Paul Gerrard
Vice President, McDermott Will & Emery
Bernd Goergen
Partner, High-Tech Gründerfonds
Jeffrey Kadanoff
MBA, Managing Director, Esplanade
Wouter Meuleman
Partner, Illumina Ventures
John Riddle
Managing Director, Brown Gibbons Lang & Company
Erika Stanzl
Associate Partner, McKinsey & Company
Dirk Voelkel
Vice President Innovation, Cytiva
Roy Wiesner
Managing Director, aMoon
André Zimmermann
Partner, SHS Capital
Mirko Stange
Initator 42plus1 & DxPx, lino Biotech
Submit your pitch, gain visibility and receive feedback by
The Roadmap through our galaxy.
Pitch.
Submit your pitch and win one of 8 spots to show off your business live at this year’s DxPx Conference in Düsseldorf.
Grow.
Win.
Among the Top 8, you will compete with the best startups worldwide live on the DxPx stage. Do you have what it takes?